NCT02560558View on ClinicalTrials.gov

Bela 8 Week Dosing

PHASE4CompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

August 29, 2019

Study Completion Date

August 29, 2019

Conditions
Kidney Transplantation
Interventions
DRUG

Belatacept

Belatacept is an immunosuppressive medication and will be given as an intravenous infusion at a dose of 5 mg/kg at 4-weekly or 8-weekly intervals.

Trial Locations (2)

30322

Emory Clinic, Atlanta

Emory University Hospital, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT02560558 - Bela 8 Week Dosing | Biotech Hunter | Biotech Hunter